Improved Local Anesthesia at Inflamed Tissue Using the Association of Articaine and Copaiba Oil in Avocado Butter Nanostructured Lipid Carriers
Authors:
- Gustavo Henrique Rodrigues da SilvaGustavo Henrique Rodrigues da Silva
- Julia Borges Paes LemesJulia Borges Paes Lemes
- Gabriela GeronimoGabriela Geronimo
- Fabíola Vieira de CarvalhoFabíola Vieira de Carvalho
- Talita Cesarim MendonçaTalita Cesarim Mendonça
- Kauê Franco MalangeKauê Franco Malange
- Fernando Freitas de LimaFernando Freitas de Lima
- Márcia Cristina BreitkreitzMárcia Cristina Breitkreitz
- Carlos Amilcar ParadaCarlos Amilcar Parada
- Teresa Dalla CostaTeresa Dalla Costa
- Eneida de PaulaEneida de Paula
Open Access
- 5 April 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (4) , 546
Abstract
Unsuccessful anesthesia often occurs under an inflammatory tissue environment, making dentistry treatment extremely painful and challenging. Articaine (ATC) is a local anesthetic used at high (4%) concentrations. Since nanopharmaceutical formulations may improve the pharmacokinetics and pharmacodynamics of drugs, we encapsulated ATC in nanostructured lipid carriers (NLCs) aiming to increase the anesthetic effect on the inflamed tissue. Moreover, the lipid nanoparticles were prepared with natural lipids (copaiba (Copaifera langsdorffii) oil and avocado (Persia gratissima) butter) that added functional activity to the nanosystem. NLC-CO-A particles (~217 nm) showed an amorphous lipid core structure according to DSC and XDR. In an inflammatory pain model induced by λ-carrageenan in rats, NLC-CO-A improved (30%) the anesthetic efficacy and prolonged anesthesia (3 h) in relation to free ATC. In a PGE2-induced pain model, the natural lipid formulation significantly reduced (~20%) the mechanical pain when compared to synthetic lipid NLC. Opioid receptors were involved in the detected analgesia effect since their blockage resulted in pain restoration. The pharmacokinetic evaluation of the inflamed tissue showed that NLC-CO-A decreased tissue ATC elimination rate (ke) by half and doubled ATC’s half-life. These results present NLC-CO-A as an innovative system to break the impasse of anesthesia failure in inflamed tissue by preventing ATC accelerated systemic removal by the inflammatory process and improving anesthesia by its association with copaiba oil.Keywords
Funding Information
- São Paulo Research Foundation (17/15174-5, 2019/17784-0, 19/2551-0002278-6)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (17/15174-5, 2019/17784-0, 19/2551-0002278-6)
- INCT-Bioanalítica (17/15174-5, 2019/17784-0, 19/2551-0002278-6)
This publication has 50 references indexed in Scilit:
- Local Anesthetics: Review of Pharmacological ConsiderationsAnesthesia Progress, 2012
- Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug DeliveryJournal of Drug Delivery, 2011
- Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular deliveryNanotechnology, 2010
- Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitriteJournal of Inflammation Research, 2008
- The effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticlesNanotechnology, 2008
- Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering☆Advanced Drug Delivery Reviews, 2007
- MicrodialysisClinical Pharmacokinetics, 2005
- How to overcome failed local anaesthesiaBritish Dental Journal, 1999
- Clinical Pharmacokinetics of ArticaineClinical Pharmacokinetics, 1997
- Microdialysis—principles and applications for studies in animals and manJournal of Internal Medicine, 1991